ROOTS Pharmaceutical is delighted to reflect on its successful participation in CPHI Riyadh 2024, a premier platform for pharmaceutical professionals and industry leaders in the Kingdom of Saudi Arabia. The event served as an excellent opportunity to connect with key stakeholders, explore new business opportunities, and reaffirm our commitment to fostering impactful collaborations in the GCC markets.
During the event, ROOTS Pharmaceutical introduced its comprehensive range of services and expertise to major players in the KSA market, including SAJA and SUDAIR. These interactions underscored our dedication to forging promising partnerships and exploring outsourcing opportunities that align with the region’s dynamic healthcare landscape. With capabilities spanning medical, pharmacovigilance, regulatory and registration processes, marketing, market access, and strategic governmental affairs, ROOTS Pharmaceutical is uniquely positioned to support endeavours that drive mutual success.
Additionally, ROOTS engaged with the MENAGEN booth, initiating discussions that have progressed toward partnership activation. These collaborations highlight our strategic focus on building long-term, value-driven relationships to deliver innovative healthcare solutions across the GCC region.
The event also provided a platform for ROOTS to strengthen ties with existing partners, such as WAYMADE pharmaceutical. Meetings focused on expanding the portfolio of collaborations, further enhancing our ability to meet the evolving needs of healthcare providers and patients alike.